sulfonylurea vs glp 1 Sulphonylureas in the management of type 2 diabetes: To be or not to be? Newer diabetes medications preferred over

Description

Midis GLP-1 prescriptions can be an accessible option, and when paired with care from our expert clinicians, they can be a game-changer

enrolled 46 type 2 DM patients with mild to moderate DPN ( Brock et al

Mechanism In response to a previous FDA inquiry, two short-term mechanical studies were conducted using exenatide and liraglutide in a diabetic rat model, wherein one rat administered with exenatide died of pancreatic necrosis, while the others exhibited acinar-to-ductal metaplasia and ductal hyperplasia, indicative of potential premalignant alterations [62,63]

For example, in patients with type 2 diabetes and obesity, certain GLP1 agents have demonstrated weight loss of 5%15% or more over a period of months to years

Semaglutide may be appropriate if you: Have a body mass index (BMI) of 27 or higher with weight-related health conditions Struggle with hunger, cravings, or portion control Have tried dieting and exercise without lasting success Are looking for a physician-supervised, non-surgical weight loss option Our medical team conducts a thorough consultation to evaluate your health history and goals before beginning treatment